#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14268	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2507	700.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1623	1623	C	886	C,T,A	884,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24142	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3959	759.9	0	.	n	.	0	T695C	SNP	695	695	T	1241	1241	C	903	C,A,G	898,3,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24142	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3959	759.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1883	1883	A	954	A,T	953,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24142	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3959	759.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2517	2517	C	823	C,T,G	821,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24142	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3959	759.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2591	2591	A	738	A,C	736,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24142	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3959	759.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3143	3143	C	836	C,A	834,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2166	folP	855	855	100.0	folP.l15.c4.ctg.1	2008	134.1	1	SNP	p	R229S	0	.	.	685	687	CGC	1290	1292	CGC	196;196;197	C,A;G;C	195,1;196;197	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5134	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3854	166.1	1	SNP	p	S91F	0	.	.	271	273	TCC	839	841	TCC	192;191;193	T,G;C;C,A	191,1;191;192,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5134	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3854	166.1	1	SNP	p	D95G	0	.	.	283	285	GAC	851	853	GAC	201;199;201	G;A,C;C	201;198,1;201	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5134	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3854	166.1	1	SNP	p	D95N	0	.	.	283	285	GAC	851	853	GAC	201;199;201	G;A,C;C	201;198,1;201	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1840	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1893	121.3	1	SNP	p	G45D	1	.	.	133	135	GAC	709	711	GAC	205;206;206	G;A,G,C;C,A	205;204,1,1;205,1	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1028	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	1349	94.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4992	parC	2304	2304	99.83	parC.l6.c4.ctg.1	3516	177.1	1	SNP	p	D86N	0	.	.	256	258	GAC	785	787	GAC	229;229;230	G;A;C	229;229;230	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4992	parC	2304	2304	99.83	parC.l6.c4.ctg.1	3516	177.1	1	SNP	p	S88P	0	.	.	262	264	TCC	791	793	TCC	229;232;233	T,C;C;C	228,1;232;233	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4102	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3060	166.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1736	1738	GGC	245;246;247	G;G,T;C,A	245;245,1;246,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3654	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2892	157.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1469	1471	GCA	215;214;212	G,T,A;C,G,A;A	213,1,1;212,1,1;212	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3654	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2892	157.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1472	1474	ATC	212;211;206	A;T;C,A	212;211;204,2	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3654	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2892	157.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1484	1486	GTG	205;204;204	G,T;T;G	204,1;204;204	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3654	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2892	157.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1484	1486	GTG	205;204;204	G,T;T;G	204,1;204;204	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3654	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2892	157.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1988	1990	ACC	196;198;199	A;C,T,A;C,T	196;196,1,1;198,1	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3654	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2892	157.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2042	2044	GCG	194;193;190	G;C;G	194;193;190	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3654	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2892	157.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2042	2044	GCG	194;193;190	G;C;G	194;193;190	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3654	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2892	157.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2165	2167	GGC	219;222;220	G;G,T,A;C,A	219;220,1,1;219,1	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3654	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2892	157.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2174	2176	GGC	220;222;217	G,A;G;C,T,A	219,1;222;215,1,1	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3654	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2892	157.7	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2192	2194	CTG	232;228;226	C;T;G,T	232;228;225,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5312	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3644	181.7	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1820	1822	CCG	202;202;203	C;C;G	202;202;203	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2430	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2133	141.8	0	.	p	.	0	S22G	NONSYN	64	66	AGC	549	551	GGC	164;164;166	G;G,A;C,T	164;163,1;165,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2430	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2133	141.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	731	731	C	200	C	200	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2682	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1912	173.4	1	SNP	p	G120K	1	G120K	NONSYN	358	360	GGC	876	878	AAG	247;248;247	A,T;A,G,C;G	246,1;246,1,1;247	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2682	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1912	173.4	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	945	947	CAA	237;237;238	C;A;A	237;237;238	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2682	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1912	173.4	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1152	1154	GAT	237;238;239	G,T;A;T	236,1;238;239	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2682	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1912	173.4	0	.	p	.	0	H213G	NONSYN	637	639	CAT	1155	1157	GGT	238;236;235	G;G,T;T,A	238;235,1;234,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2682	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1912	173.4	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1161	1163	GCT	240;237;238	G,T;C;T,C	238,2;237;237,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2682	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1912	173.4	0	.	p	.	0	G255R	NONSYN	763	765	GGA	1281	1283	AGA	190;189;186	A;G;A,T	190;189;185,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2682	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1912	173.4	0	.	p	.	0	R257T	NONSYN	769	771	AGG	1287	1289	ACG	182;178;177	A;C;G,T	182;178;176,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2682	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1912	173.4	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1293	1295	GTT	178;179;179	G;T;T	178;179;179	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2682	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1912	173.4	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1407	1409	AAC	211;214;215	A;A;C	211;214;215	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2682	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1912	173.4	1	SNP	p	A121D	1	.	.	361	363	GAC	879	881	GAC	245;248;247	G;A,G;C,A	245;247,1;246,1	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2682	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1912	173.4	1	SNP	p	D121N	0	.	.	361	363	GAC	879	881	GAC	245;248;247	G;A,G;C,A	245;247,1;246,1	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9444	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	5413	217.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1444	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	1495	120.3	1	SNP	p	V57M	1	.	.	169	171	ATG	691	693	ATG	256;258;260	A,C;T,G;G	255,1;257,1;260	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
